Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

insulin glargine

once daily

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Prague

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00659477 - Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) | Biotech Hunter | Biotech Hunter